Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengguo Xing

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|April 16, 2025
An LC-MS/MS method for the quantification of tobacco-specific carcinogen protein adductsBreanne Freeman, Chengguo Xing
Chemical Research in Toxicology|September 3, 2025
An LC-MS/MS Method for the Quantification of Tobacco-Specific Carcinogen Protein AdductsBreanne Freeman, Chengguo Xing
Medicinal Chemistry|January 23, 2016
Diverse Molecular Targets for Chalcones with Varied BioactivitiesBo Zhou, Chengguo Xing
Bioanalysis|November 10, 2018
Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MSYi Wang, Naomi Fujioka, Chengguo Xing
Molecular Pharmaceutics|September 19, 2007
Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosisJignesh M Doshi, Defeng Tian, Chengguo Xing
Bioorganic & Medicinal Chemistry Letters|November 30, 2010
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studiesBalasubramanian Srinivasan, Thomas E Johnson, Chengguo Xing
Journal of Medicinal Chemistry|December 22, 2006
Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancerJignesh M Doshi, Defeng Tian, Chengguo Xing
Journal of Dietary Supplements|March 22, 2012
Diets, phytochemicals, and chemoprevention of tumorigenesisChengguo Xing, Thomas E Johnson, Paul J Limburg
Anticancer Research|September 21, 2012
A new chalcone derivative (E)-3-(4-methoxyphenyl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one suppresses prostate cancer involving p53-mediated cell cycle arrests and apoptosisYong Zhang, Balasubramanian Srinivasan, Chengguo Xing, et al.
Medchemcomm|August 16, 2018
Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 functionChunlin Zhuang, Zhongli Wu, Chengguo Xing, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|April 16, 2025
An LC-MS/MS method for the quantification of tobacco-specific carcinogen protein adductsBreanne Freeman, Chengguo Xing
Chemical Research in Toxicology|September 3, 2025
An LC-MS/MS Method for the Quantification of Tobacco-Specific Carcinogen Protein AdductsBreanne Freeman, Chengguo Xing
Medicinal Chemistry|January 23, 2016
Diverse Molecular Targets for Chalcones with Varied BioactivitiesBo Zhou, Chengguo Xing
Bioanalysis|November 10, 2018
Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MSYi Wang, Naomi Fujioka, Chengguo Xing
Molecular Pharmaceutics|September 19, 2007
Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosisJignesh M Doshi, Defeng Tian, Chengguo Xing
Bioorganic & Medicinal Chemistry Letters|November 30, 2010
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studiesBalasubramanian Srinivasan, Thomas E Johnson, Chengguo Xing
Journal of Medicinal Chemistry|December 22, 2006
Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancerJignesh M Doshi, Defeng Tian, Chengguo Xing
Journal of Dietary Supplements|March 22, 2012
Diets, phytochemicals, and chemoprevention of tumorigenesisChengguo Xing, Thomas E Johnson, Paul J Limburg
Anticancer Research|September 21, 2012
A new chalcone derivative (E)-3-(4-methoxyphenyl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one suppresses prostate cancer involving p53-mediated cell cycle arrests and apoptosisYong Zhang, Balasubramanian Srinivasan, Chengguo Xing, et al.
Medchemcomm|August 16, 2018
Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 functionChunlin Zhuang, Zhongli Wu, Chengguo Xing, et al.
Pageof 12